Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term biomarkers. Found 16 abstracts

Bodor JN, Boumber Y, Borghaei H. Biomarkers for immune checkpoint inhibition in non-small cell lung cancer (NSCLC). Cancer. 2019 Nov 06;.
Anari F, Ramamurthy C, Zibelman M. Impact of tumor microenvironment composition on therapeutic responses and clinical outcomes in cancer. Future Oncol. 2018 Jun;14(14):1409-21.
Herceg Z, Ghantous A, Wild CP, Sklias A, Casati L, Duthie SJ, Fry R, Issa JP, Kellermayer R, Koturbash I, Kondo Y, Lepeule J, Lima SC, Marsit CJ, Rakyan V, Saffery R, Taylor JA, Teschendorff AE, Ushijima T, Vineis P, Walker CL, Waterland RA, Wiemels J, Ambatipudi S, Degli Esposti D, Hernandez-Vargas H. Roadmap for investigating epigenome deregulation and environmental origins of cancer. International journal of cancer. 2018 Mar;142(5):874-82.   PMCID: PMC6027626
Gerstenhaber JA, Barone FC, Marcinkiewicz C, Li J, Shiloh AO, Sternberg M, Lelkes PI, Feuerstein G. Vascular thrombus imaging in vivo via near-infrared fluorescent nanodiamond particles bioengineered with the disintegrin bitistatin (Part II). International journal of nanomedicine. 2017 Nov;12:8471-82.   PMCID: PMC5703177
Ribas A, Dummer R, Puzanov I, VanderWalde A, Andtbacka RH, Michielin O, Olszanski AJ, Malvehy J, Cebon J, Fernandez E, Kirkwood JM, Gajewski TF, Chen L, Gorski KS, Anderson AA, Diede SJ, Lassman ME, Gansert J, Hodi FS, Long GV. Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy. Cell. 2017 Sep 07;170(6):1109-1119e10.
Beck TN, Kaczmar J, Handorf E, Nikonova A, Dubyk C, Peri S, Lango M, Ridge JA, Serebriiskii IG, Burtness B, Golemis EA, Mehra R. Phospho-T356RB1 predicts survival in HPV-negative squamous cell carcinoma of the head and neck. Oncotarget. 2015 Aug 07;6(22):18863-74.   PMCID: 4662460
Kaczmar J, Mehra R. HPV-negative head and neck squamous cell carcinomas: how can we use the tumor protein signature?. Biomark Med. 2015 Mar;9(3):183-5.
Movva S, Wen W, Chen W, Millis SZ, Gatalica Z, Reddy S, von Mehren M, Van Tine BA. Multi-platform profiling of over 2000 sarcomas: Identification of biomarkers and novel therapeutic targets. Oncotarget. 2015 Mar 26;6(14):12234-47.   PMCID: 4494935
Block T, Mehta AS, London WT. Hepatocellular carcinoma of the liver. Cancer Biomarkers. 2011 Jan;9(1-6):375-83.   PMCID: not NIH funded
Sasaroli D, Gimotty PA, Pathak HB, Hammond R, Kougioumtzidou E, Katsaros D, Buckanovich R, Devarajan K, Sandaltzopoulos R, Godwin AK, Scholler N, Coukos G, Stellani P VP. Novel surface targets and serum biomarkers from the ovarian cancer vasculature. Cancer Biology & Therapy. 2011 Aug;12(3):169-80.   PMCID: PMC3230481
Atkins MB, Bukowski RM, Escudier BJ, Figlin RA, Hudes GH, Kaelin WG, Linehan WM, McDermott DF, Mier JW, Pedrosa I, Rini BI, Signoretti S, Sosman JA, Teh BT, Wood CG, Zurita AJ, King L. Innovations and Challenges in Renal Cancer: Summary Statement From the Third Cambridge Conference. Cancer . 2009 Jan;115(10):2247-51.   PMCID: PMC2892290
Kashyap MK, Marimuthu A, Kishore CJ, Peri S, Keerthikumar S, Prasad TS, Mahmood R, Rao S, Ranganathan P, Sanjeeviah RC, Vijayakumar M, Kumar KV, Montgomery E, Kumar RV, Pandey A. Genomewide mRNA profiling of esophageal squamous cell carcinoma for identification of cancer biomarkers. Cancer Biology & Therapy. 2009 Jan;8(1):36-46.   PMCID: not NIH funded
Block TM, Marrero J, Gish RG, Sherman M, London WT, Srivastava S, Wagner PD. The degree of readiness of selected biomarkers for the early detection of hepatocellular carcinoma: Notes from a recent workshop. Cancer Biomarkers. 2008 Jan;4(1):19-33.
Bane AL, Beck JC, Bleiweiss I, Buys SS, Catalano E, Daly MB, Giles G, Godwin AK, Hibshoosh H, Hopper JL, John EM, Layfield L, Longacre T, Miron A, Senie R, Southey MC, West DW, Whittemore AS, Wu H, Andrulis IL, O'Malley FP. BRCA2 mutation-associated breast cancers exhibit a distinguishing phenotype based on morphology and molecular profiles from tissue microarrays. American Journal of Surgical Pathology. 2007 Jan;31(1):121-8.
Comunale MA, Lowman M, Long RE, Krakover J, Philip R, Seeholzer S, Evans AA, Hann HW, Block TM, Mehta AS. Proteomic analysis of serum associated fucosylated glycoproteins in the development of primary hepatocellular carcinoma. JOURNAL OF PROTEOME RESEARCH. 2006 Feb;5(2):308-15.
Mason TJ, Walsh WP, Lee K, Vogler W. New opportunities for screening and early detection of bladder cancer. Journal of cellular biochemistry. 1992 Jan;50(SUPPL. 16 I):13-22.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term biomarkers

biomarkers genetics immunotherapy gene-expression head and neck cancer CARRIERS alpha-fetoprotein cancer cirrhosis tumor carcinoma T lymphocytes Programmed Cell Death 1 Receptor glycomics hepatitis C IMMUNOHISTOCHEMICAL MARKERS pathology hepatitis-b virus E2f hepatocellular carcinoma antagonists & inhibitors administration & dosage CHRONIC HBV INFECTION fluorescent nanodiamond particles Biochemical Research Methods GENE-EXPRESSION PROFILE Hepatocellular carcinoma estrogen receptor biochemical markers bladder cancer molecular pathogenesis familial oncolytic immunotherapy chronic viral-hepatitis breast cancer liver-cancer epigenetics OVARIAN-CANCER SURGICAL ADJUVANT BREAST tissue microarrays screening ovarian programmed death ligand 1 (PD-L1) protein expression fucosylation angiogenesis therapy research gaps WOMEN C-VIRUS SERUM VIRAL LOAD diagnostics hepatitis B TUMOR CHARACTERISTICS oncolytic viruses GLYPICAN-3 EXPRESSION vessels p16 negative Combined Modality Therapy environment vascular endothelial growth factor anti-PD-1 Cdk4 BRCA2 molecular mechanisms perspectives glycosylation pattern fibrosis IN-VITRO Oncolytic Virotherapy early cancer adverse effects COLORECTAL-CANCER contribute expression profiling SERINE-PROTEASE tumor-markers correlate GERMLINE MUTATIONS pembrolizumab EXPRESSION MATRIX METALLOPROTEINASE-2 CHRONIC LIVER-DISEASE talimogene laherparepvec united-states Tumor Microenvironment ALPHA-FETOPROTEIN expression non-small-cell lung cancer bevacizumab glycan molecular oncology oncogenes profiling markers DNA microarrays GASTRIC-CANCER 1984 ugnier y-hepatology-v4-p889 HPV negative Herpesviridae targeted therapies early FAMILY REGISTRY Melanoma Rb1 hematuria TUMOR PROGRESSION Liver Cancer esophageal squamous cell carcinoma early detection NIR fluorescence imaging tumor mutational burden (TMB) hepatocellular renal cancer DIFFERENTIAL SURVIVAL Immunotherapy PROTEIN metastasis fucosylated glycoproteins Monoclonal Antibodies-Humanized interferon gamma CDNA MICROARRAY cytotixic thrombosis vascular serum HEPATITIS-B-VIRUS early diagnosis sarcoma LYMPH-NODE METASTASIS 6 melanoma serum glycoproteins detection endothelial-cells DNA sequencing ESTROGEN-RECEPTOR STATUS hepatitis-c virus
Last updated on Wednesday, February 05, 2020